EVGN

#4941
EVOGENE LTD.
0.82 USD
0.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
0.82
0.82
Rango anual
0.72
2.42
Cambio diario
0.00%
Variación mensual
-1.20%
Variación en los últimos 6 meses
-38.35%
Cambio anual
-21.90%
Cierres anteriores
0.82
Abrir
0.82
Bid
Ask
Mínimo
0.82
High
0.82
Volumen
5
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 7.15 M
  • Employee 52
  • Founded 1999
  • CEO Ofer Haviv
  • Website www.evogene.com
  • Headquarter Israel
  • FIGI UNKNOWN
  • Industry Technology
Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Evogene Ltd

Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture.

Noticias